Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05781113 · ClinicalTrials.gov registry record

A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition

A clinical trial of Multiple Sclerosis, sponsored by Celestra Health Systems.

Active
Registry status
90
Enrollment target
3
Study locations

NCT05781113 is a study of Multiple Sclerosis that is active but no longer recruiting, run by Celestra Health Systems. The registered enrollment target is 90 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05781113, a study of Multiple Sclerosis, is active but no longer recruiting, sponsored by Celestra Health Systems.

ACTIVE NOT RECRUITING
Registry status
90 participants
Enrollment target
3
Study locations

Study Summary

To measure the effectiveness of a Remote Patient Monitoring solution based on the use of a smart insole wearable device (and associated smart phone app), for monitoring MS patients' condition on a day-to-day basis. The main focus is the objective measurement of gait, given that 75% of people with MS display clinically significant gait impairments. Initial gait lab "gold standard" data indicate that the Artificial Intelligence (AI)-based digital biomarker will prove to be highly effective at detecting changes in the MS patient's condition.

Conditions Studied

Multiple Sclerosis

Study Locations (3)

Massachusetts

  • Brigham and Women's Hospital - Boston

Ontario

  • The Ottawa Hospital - Ottawa

Other

  • The Royal London Hospital - London

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2023-07-01
Est. Completion 2026-12-31

Sponsor

Celestra Health Systems

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05781113

The ClinicalTrials.gov registry entry for NCT05781113 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (85% lower). The listed sponsor is Celestra Health Systems, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT05781113 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Ontario, Other.

Frequently Asked Questions

What is clinical trial NCT05781113 about?

NCT05781113 is a clinical study titled "A Novel Wearable Digital Biomarker for Detecting Changes in Multiple Sclerosis (MS) Condition". To measure the effectiveness of a Remote Patient Monitoring solution based on the use of a smart insole wearable device (and associated smart phone app), for monitoring MS patients' condition on a day-to-day basis. The main focus is the objective measurement of gait, given that 75% of people with MS...

What is the current status of trial NCT05781113?

This trial is currently active not recruiting. The enrollment target is 90 participants. The study started on 2023-07-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05781113 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT05781113?

This trial is sponsored by Celestra Health Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05781113 being conducted?

This trial has 3 study locations across Massachusetts, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.